{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:32:38Z","timestamp":1790184758810,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T00:00:00Z","timestamp":1704758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T00:00:00Z","timestamp":1704758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s11096-023-01679-6","type":"journal-article","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T12:02:07Z","timestamp":1704801727000},"page":"574-589","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The clinical and economic evidence of the management of urinary tract infections by community pharmacists in women aged 16 to 65\u00a0years: a systematic review"],"prefix":"10.1007","volume":"46","author":[{"given":"Ansonette","family":"Swart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9768-7838","authenticated-orcid":false,"given":"Shalom I.","family":"Benrimoj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7080-0108","authenticated-orcid":false,"given":"Sarah","family":"Dineen-Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,9]]},"reference":[{"issue":"12","key":"1679_CR1","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nrurol.2010.190","volume":"7","author":"B Foxman","year":"2010","unstructured":"Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol. 2010;7(12):653\u201360.","journal-title":"Nat Rev Urol"},{"issue":"3","key":"1679_CR2","doi-asserted-by":"publisher","first-page":"359","DOI":"10.12816\/0003256","volume":"13","author":"A Al-Badr","year":"2013","unstructured":"Al-Badr A, Al-Shaikh G. Recurrent urinary tract infections management in women: a review. Sultan Qaboos Univ Med J. 2013;13(3):359\u201367.","journal-title":"Sultan Qaboos Univ Med J"},{"key":"1679_CR3","doi-asserted-by":"crossref","unstructured":"Geerlings SE. Clinical presentations and epidemiology of urinary tract infections. Microbiol Spectr. 2016;4(5).","DOI":"10.1128\/microbiolspec.UTI-0002-2012"},{"key":"1679_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1477-7525-3-45","volume":"3","author":"EJ Ernst","year":"2005","unstructured":"Ernst EJ, Ernst ME, Hoehns JD, et al. Women\u2019s quality of life is decreased by acute cystitis and antibiotic adverse effects associated with treatment. Health Qual Life Outcomes. 2005;3:45.","journal-title":"Health Qual Life Outcomes"},{"key":"1679_CR5","volume-title":"General practice activity in Australia 2015\u201316","author":"H Britt","year":"2016","unstructured":"Britt H, Miller GC, Henderson J, et al. General practice activity in Australia 2015\u201316. Sydney: Sydney University Press; 2016."},{"key":"1679_CR6","unstructured":"Australian Commission on Safety and Quality in Health Care. Fourth Australian Atlas of Healthcare Variation. 2021. https:\/\/www.safetyandquality.gov.au\/our-work\/healthcare-variation\/fourth-atlas-2021\/chronic-disease-and-infection-potentially-preventable-hospitalisations\/24-kidney-infections-and-urinary-tract-infections. Accessed 20 Aug 2023."},{"key":"1679_CR7","unstructured":"Australian Institute of Health and Welfare. Emergency department care 2019\u201320: Australian hospital statistics. Table 4.5: Emergency department presentations(a) by principal diagnosis in ICD\u201110\u2011AM(b) chapters, states and territories, 2019\u201320. 2021. https:\/\/www.aihw.gov.au\/getmedia\/433caea4-03ff-4569-96ac-042f2844f29c\/Emergency-department-care-2019-20.xlsx.aspx. Accessed 20 Aug 2023."},{"key":"1679_CR8","unstructured":"Australian Medical Association. The general practitioner workforce: why the neglect must end. 2022. Accessed 20 Aug 2023."},{"key":"1679_CR9","unstructured":"Australian Bureau of Statistics. Patient Experiences: Australian Bureau of Statistics. 2022. https:\/\/www.abs.gov.au\/statistics\/health\/health-services\/patient-experiences\/latest-release. Accessed 20 Aug 2023."},{"issue":"1","key":"1679_CR10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12962-020-00220-0","volume":"18","author":"S Dineen-Griffin","year":"2020","unstructured":"Dineen-Griffin S, Vargas C, Williams KA, et al. Cost utility of a pharmacist-led minor ailment service compared with usual pharmacist care. Cost Effectiven Resour Alloc. 2020;18(1):24.","journal-title":"Cost Effectiven Resour Alloc"},{"issue":"1","key":"1679_CR11","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1186\/s12913-019-4780-z","volume":"19","author":"SA Trankle","year":"2019","unstructured":"Trankle SA, Usherwood T, Abbott P, et al. Integrating health care in Australia: a qualitative evaluation. BMC Health Serv Res. 2019;19(1):954.","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"1679_CR12","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.sapharm.2022.10.007","volume":"19","author":"A Urionag\u00fcena","year":"2023","unstructured":"Urionag\u00fcena A, Piquer-Martinez C, Gastelurrutia M\u00c1, et al. Community pharmacy and primary health care\u2014types of integration and their applicability: a narrative review. Res Social Adm Pharm. 2023;19(3):414\u201331.","journal-title":"Res Social Adm Pharm"},{"issue":"2","key":"1679_CR13","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.18549\/PharmPract.2020.2.1967","volume":"18","author":"S Dineen-Griffin","year":"2020","unstructured":"Dineen-Griffin S, Benrimoj SI, Garcia-Cardenas V. Primary health care policy and vision for community pharmacy and pharmacists in Australia. Pharm Pract (Granada). 2020;18(2):1967.","journal-title":"Pharm Pract (Granada)"},{"issue":"612","key":"1679_CR14","doi-asserted-by":"publisher","first-page":"e472","DOI":"10.3399\/bjgp13X669194","volume":"63","author":"V Paudyal","year":"2013","unstructured":"Paudyal V, Watson MC, Sach T, et al. Are pharmacy-based minor ailment schemes a substitute for other service providers? A systematic review. Br J Gen Pract. 2013;63(612):e472\u201381.","journal-title":"Br J Gen Pract"},{"issue":"9","key":"1679_CR15","first-page":"1","volume":"9","author":"N Peiffer-Smadja","year":"2020","unstructured":"Peiffer-Smadja N, Allison R, Jones LF, et al. Preventing and managing urinary tract infections: enhancing the role of community pharmacists\u2014a mixed methods study. Antibiotics (Basel). 2020;9(9):1\u201313.","journal-title":"Antibiotics (Basel)"},{"issue":"1","key":"1679_CR16","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s11096-022-01430-7","volume":"45","author":"JE Isenor","year":"2023","unstructured":"Isenor JE, Cossette B, Murphy AL, et al. Community pharmacists\u2019 expanding roles in supporting patients before and during COVID-19: an exploratory qualitative study. Int J Clin Pharm. 2023;45(1):64\u201378.","journal-title":"Int J Clin Pharm"},{"key":"1679_CR17","first-page":"7945","volume":"306","author":"F Lee","year":"2021","unstructured":"Lee F, Motta M, Wilcock M. Evaluation of a community pharmacy service for uncomplicated urinary tract infection. Pharm J. 2021;306:7945.","journal-title":"Pharm J"},{"key":"1679_CR18","unstructured":"New Brunswick College of Pharmacists. Pharmacists\u2019 Expanded Scope: Minor Ailments. 2014."},{"key":"1679_CR19","unstructured":"Nissen L, Spinks J, Lau E. The management of urinary tract infections by community pharmacists: a state-wide trial: urinary tract infection pharmacy pilot - Queensland (Outcome Report). 2022."},{"key":"1679_CR20","unstructured":"NSW Health. Pharmacy reform to expand community health care. 2022. https:\/\/www.health.nsw.gov.au\/news\/Pages\/20221113_00.aspx. Accessed 20 Aug 2023."},{"key":"1679_CR21","volume-title":"Cochrane handbook for systematic reviews of interventions version 64","author":"M Pollock","year":"2023","unstructured":"Pollock M, Fernandes RM, Becker LA, et al. Chapter V: overviews of reviews. In: Higgins JPT, Thomas J, Chandler J, et al., editors. Cochrane handbook for systematic reviews of interventions version 64. New York: Cochrane; 2023."},{"key":"1679_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n160","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, Moher D, Bossuyt PM, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372: n160.","journal-title":"BMJ"},{"issue":"5","key":"1679_CR23","first-page":"295","volume":"39","author":"A Chung","year":"2010","unstructured":"Chung A, Arianayagam M, Rashid P. Bacterial cystitis in women. Aust Fam Physician. 2010;39(5):295\u20138.","journal-title":"Aust Fam Physician"},{"key":"1679_CR24","unstructured":"Joanna Briggs Institute Critical Appraisal Tools. 2020. https:\/\/jbi.global\/critical-appraisal-tools. Accessed 20 Aug 2023."},{"issue":"5","key":"1679_CR25","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1177\/1715163518781175","volume":"151","author":"NP Beahm","year":"2018","unstructured":"Beahm NP, Smyth DJ, Tsuyuki RT. Outcomes of urinary tract infection management by pharmacists (RxOUTMAP): a study of pharmacist prescribing and care in patients with uncomplicated urinary tract infections in the community. Canad Pharm J. 2018;151(5):305\u201314.","journal-title":"Canad Pharm J"},{"issue":"3","key":"1679_CR26","first-page":"205","volume":"6","author":"NP Beahm","year":"2021","unstructured":"Beahm NP, Smyth DJ, Tsuyuki RT. Antimicrobial utilization and stewardship in patients with uncomplicated urinary tract infections managed by pharmacists in the community: a sub-study of the rxoutmap trial. JAMMI. 2021;6(3):205\u201312.","journal-title":"JAMMI"},{"issue":"1","key":"1679_CR27","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1186\/s12913-019-4303-y","volume":"19","author":"C Sanyal","year":"2019","unstructured":"Sanyal C, Husereau DR, Beahm NP, et al. Cost-effectiveness and budget impact of the management of uncomplicated urinary tract infection by community pharmacists. BMC Health Serv Res. 2019;19(1):499.","journal-title":"BMC Health Serv Res"},{"issue":"609","key":"1679_CR28","doi-asserted-by":"publisher","first-page":"E244","DOI":"10.3399\/bjgp13X665206","volume":"63","author":"JL Booth","year":"2013","unstructured":"Booth JL, Mullen AB, Thomson DA, et al. Antibiotic treatment of urinary tract infection by community pharmacists: a cross-sectional study. Br J Gen Pract. 2013;63(609):E244\u20139.","journal-title":"Br J Gen Pract"},{"key":"1679_CR29","unstructured":"Hind C. NHS Grampian project: treating uncomplicated lower urinary tract infection in community pharmacy. Clin Pharm. 2018;10(1)."},{"issue":"5","key":"1679_CR30","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1016\/j.sapharm.2021.07.003","volume":"18","author":"D Stampfli","year":"2022","unstructured":"Stampfli D, Winkler BA, Vilei SB, et al. Assessment of minor health disorders with decision tree-based triage in community pharmacies. Res Soc Adm Pharm. 2022;18(5):2867\u201373.","journal-title":"Res Soc Adm Pharm"},{"issue":"6","key":"1679_CR31","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1017\/S1463423617000925","volume":"19","author":"F Stewart","year":"2018","unstructured":"Stewart F, Caldwell G, Cassells K, et al. Building capacity in primary care: the implementation of a novel \u201cPharmacy First\u201d scheme for the management of UTI, impetigo and COPD exacerbation. Prim Health Care Res Dev. 2018;19(6):531\u201341.","journal-title":"Prim Health Care Res Dev"},{"key":"1679_CR32","doi-asserted-by":"crossref","unstructured":"Thornley T, Kirkdale CL, Beech E, et al. Evaluation of a community pharmacy-led test-and-treat service for women with uncomplicated lower urinary tract infection in England. JAC Antimicrob Resistance. 2020;2(1).","DOI":"10.1093\/jacamr\/dlaa010"},{"issue":"1","key":"1679_CR33","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s11096-016-0415-1","volume":"39","author":"NJ Gauld","year":"2017","unstructured":"Gauld NJ, Zeng IS, Ikram RB, et al. Antibiotic treatment of women with uncomplicated cystitis before and after allowing pharmacist-supply of trimethoprim. Int J Clin Pharm. 2017;39(1):165\u201372.","journal-title":"Int J Clin Pharm"},{"issue":"9","key":"1679_CR34","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1111\/bcp.13624","volume":"84","author":"T Jebara","year":"2018","unstructured":"Jebara T, Cunningham S, MacLure K, et al. Stakeholders\u2019 views and experiences of pharmacist prescribing: a systematic review. Br J Clin Pharmacol. 2018;84(9):1883\u2013905.","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"1679_CR35","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1093\/jac\/dkp305","volume":"64","author":"MS Dryden","year":"2009","unstructured":"Dryden MS, Cooke J, Davey P. Antibiotic stewardship\u2014more education and regulation not more availability? J Antimicrob Chemother. 2009;64(5):885\u20138.","journal-title":"J Antimicrob Chemother"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-023-01679-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-023-01679-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-023-01679-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T18:40:40Z","timestamp":1716921640000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-023-01679-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,9]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1679"],"URL":"https:\/\/doi.org\/10.1007\/s11096-023-01679-6","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,9]]},"assertion":[{"value":"24 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there are no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}